Intrexon reported $2.07M in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Agenus AGEN:US $ 15.2M 1.37M
Amgen AMGN:US $ 295M 40M
Bristol Myers Squibb BMY:US $ 326M 3M
Chemocentryx CCXI:US $ 0.6M 0.05M
Gilead Sciences GILD:US $ 238M 0M
Immunogen IMGN:US $ 1.25M 0.9M
Intrexon XON:US $ 2.07M 2.82M
Karyopharm Therapeutics KPTI:US $ 6.68M 1.26M
Ligand Pharmaceuticals LGND:US $ 0.79M 3.68M
Mannkind MNKD:US $ 5.12M 0.98M
Merk MRK:US $ 243M 34M
Novartis NOVN:VX 201M 5M
Peregrine Pharmaceuticals PPHM:US 718K 14K
Rigel Pharmaceuticals RIGL:US $ 1.2M 0.09M
Thermo Fisher Scientific TMO:US $ 136M 25M
Veracyte VCYT:US $ 0.06M 0M
YTE INCY:US $ 0.68M 0.07M
Ziopharm Oncology ZIOP:US 683K 55K